(Q43080152)

13 November 2017

title

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges (English)

1 reference

13 November 2017

1 reference

1 reference

Satyen J Torne

1

1 reference

13 November 2017

Khalid A Ansari

2

1 reference

13 November 2017

Pradeep R Vavia

3

1 reference

13 November 2017

Francesco Trotta

4

1 reference

13 November 2017

Roberta Cavalli

5

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

17

1 reference

13 November 2017

issue

6

1 reference

13 November 2017

page(s)

419-425

1 reference

A good practice guide to the administration of substances and removal of blood, including routes and volumes

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

ABC Transporters: From Microorganisms to Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

21 January 2018

Oral delivery of taxanes

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717541003777233

10.3109/10717541003777233

21 January 2018

Identifiers

DOI

1 reference

release_ko7ost3op5h2vpke5nl6f5ax7m

13 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ko7ost3op5h2vpke5nl6f5ax7m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference